Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Papillary Breast Cancer is an uncommon type of invasive ductal breast cancer, which accounts for less than 1% of all breast cancers. Many papillary tumors are benign papillomas and these are called papillomas. Even when the biopsy is negative for cancer, the pathologist often to look around the tumor under the microscope to be sure of the diagnosis. Therefore usually recommend surgery to remove a papilloma virus, although it is thought to be benign. Malignant tumors papillary is a form of breast cancer. Like other types of invasive ductal cancer, Papillary Breast Cancer starts in the milk duct of the breast. Most of the time, papillary cancers including breast cells both in situ (not yet spread outside the duct) and invasive cells (which have started to spread outside the duct). Papillary breast cancer generally small and positive for estrogen and / or progesterone receptor (ER / PR +) and negative for the HER2 receptor (HER2). Compared with the most common types of breast cancer, papillary breast cancer are less likely to involve lymph nodes, are more sensitive to treatment, and may have a better prognosis than the more common types of invasive ductal carcinoma.
The treatment used for Papillary Breast Cancer is local therapy and systemic therapy. Local treatment is to prevent relapse of cancer of the breast. Local treatment include surgery (lumpectomy or mastectomy), and may include radiation. Systemic therapy is used to prevent the disease from returning or spreading to other parts of the body. Information about the treatment of patients with papillary carcinoma is limited, and the pattern observed in the available series suggest a different approach to this disease. This may include endocrine therapy (hormonal) therapy and chemotherapy directed against the HER2 protein. Often different types of treatment are used together to achieve the best results. The treatment plan is based on the cell type, tumor grade, hormone receptor status, HER2 status, tumor size and nodal status. Everyone knows that it can be stressful to receive a diagnosis of breast cancer, and learning that has a rare form of the disease can add to your anxiety. Many researchers devoted to the latest research and treatment of papillary cancer. The incidence of both invasive Papillary Carcinoma in situ appears to be older and older postmenopausal women, and in relative terms-in males.
OMICS Group International is a unique blend of international conferences and open access publications. OMICS Group was established in the year 2007 with an aim of “Making the information on Sciences and Technology-Open Access” It publishes journals in all aspects of Science, Engineering, Management and Technology; it publishes around 400 online open access journals. OMICS Group organizes International Conferences across the globe. Each conference has people from around the globe, and knowledge is exchanged through symposiums, workshops, poster presentations, by people who are leading researchers, noble prize winners, Educational instructors, Research Scholars, and leading scientists. OMICS Group organizes more than 300 conferences per year.
Relevant Conferences:-
1) World Congress on Breast Cancer Aug 3-5, 2015 Birmingham, UK
2) IMPAKT 2015 Breast Cancer Conference May 7-9 2015 Brussels, Belgium
3) 14 th St. Gallen International Breast Cancer Conference Primary Therapy of Early Breast Cancer 18 - 21 March 2015 Vienna, Austria.
4) 32nd Annual Miami Breast Cancer Conference Feb 26-Mar 1, 2015 Miami beach, FL
5) San Antonio Breast Cancer Symposium Dec 9-13, 2014 San Antonio, USA
6) ICBC 2015 : XIII International Conference on Breast Cancer Feb 16-17, 2015 London, UK
7) Barcelona Breast Meeting 2015 March 11-13, 2015 Barcelona, Spain
8) BreastScreen Australia Conference 2014 October 16-18, 2014 Melbourne, Australia
9) Sydney Cancer Conference 2014 Nov 27-28, 2014 Sydeny, Australia
10) 18th Annual Tyler Breast Cancer Conference March 27-28, 2015 Texas, USA
11) World Congress on Breast Cancer Aug 3-5, 2015 Birmingham, UK
12)Prostate Cancer Congress during June22-24, 2015 at Florida USA
14)<a href="http://cancer.global-summit.com/europe/>8th Euro Global Summit on Cancer Therapy
15) 5th world Congress on Cancer Therapy
16)5th Global Summit on Cancer therapy
17) World Drug Delivery Summit during August 17-19, 2015 at Houston, USA.
18)International Conference on Urology to be held from July 20-22nd , 2015 in Barcelona, Spain
19)8th Euro Global Summit on Cancer Therapy
Relevant Associations:-
1) American Cancer society, USA
2) American Society of Clinical Oncology, USA
3) German Cancer Society, Germany
4) Philippine Cancer Society, Inc. (PCSI), Philippines
5) Association of European Cancer Leagues, Europe
6) Association for International Cancer Research, UK
7) British Association of Surgical Oncology, UK
8) British Oncology Pharmacy Association, UK
9) Australian Association of Smoking Cessation Professionals, Australia
10) Australian Society of Gynaecologic Oncologists, Australia.
Companies:-
1) Abbott laboratories
2) Aeterna zentaris
3) Agendia
4) Altheadx
5) Ambergen inc.
6) Astrazeneca plc
7) Atossa genetics inc.
8) Biotime
9) Ccc diagnostics llc
10) Clarinet
11) Dako
12) Eisai inc. (headquarters)
13) Eutropics pharmaceuticals
14) Fluxion biosciences
15) Genentech
16) Genomic health
17) Glaxosmithkline
18) Life technologies
This page will be updated regularly.
This page was last updated on November 22, 2024
